Tech Company Financing Transactions

Ceterix Orthopaedics Funding Round

5AM Ventures, Novo Ventures and Oxford Finance participated in a $18 million Series B funding round for Ceterix Orthopaedics. The funding round was announced on 5/13/2014.

Transaction Overview

Company Name
Ceterix Orthopaedics
Announced On
5/13/2014
Transaction Type
Debt
Debt
Venture Equity
Venture Equity
Amount
$18,000,000
Round
Series B
Investors

5AM Ventures (Mark Collela)

Novo Ventures (Peter Bisgaard)

Oxford Finance

Silicon Valley Bank

Versant Ventures

Proceeds Purpose
Funds will be used to support commercial expansion of the company's novel surgical tools for arthroscopic procedures, currently in use by more than 100 U.S. physicians. The technology enables surgeons to place stitches in very tight joint compartments, while protecting sensitive surrounding structures such as nerves, arteries and cartilage. This technology has applications in numerous procedures in knees, hips, and shoulders.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6500 Kaiser Dr. 120
Fremont, CA 94555
USA
Phone
650-241-1748
Website
www.ceterix.com
Email Address
[email protected]
Overview
Ceterix Orthopaedics develops novel surgical tools for arthroscopic procedures.
Profile
Ceterix Orthopaedics LinkedIn Company Profile
Social Media
Ceterix Orthopaedics Company Twitter Account
Company News
Ceterix Orthopaedics News
Facebook
Ceterix Orthopaedics on Facebook
YouTube
Ceterix Orthopaedics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John McCutcheon
  John McCutcheon LinkedIn Profile  John McCutcheon Twitter Account  John McCutcheon News  John McCutcheon on Facebook
Chief Medical Officer
Justin Saliman
  Justin Saliman LinkedIn Profile  Justin Saliman Twitter Account  Justin Saliman News  Justin Saliman on Facebook
VP - Human Resources
Patty Perla
  Patty Perla LinkedIn Profile  Patty Perla Twitter Account  Patty Perla News  Patty Perla on Facebook
VP - R & D
Michael Hendricksen
  Michael Hendricksen LinkedIn Profile  Michael Hendricksen Twitter Account  Michael Hendricksen News  Michael Hendricksen on Facebook
VP - Sales
Mark Saxton
  Mark Saxton LinkedIn Profile  Mark Saxton Twitter Account  Mark Saxton News  Mark Saxton on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/13/2014: SIGNiX venture capital transaction
Next: 5/13/2014: Stratos Genomics venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.